Sonova Holding AG/Fr. SOON
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Sonova Holding AG
Sonova Holding AG is a Swiss company operating in the healthcare industry, specializing in hearing care solutions. The company offers a comprehensive range of products, including hearing aids, cochlear implants, and wireless communication systems. Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova serves a global market, providing advanced hearing care technology and services. Its strategic positioning is strengthened by continuous innovation in audiological performance and customer-centric solutions, supported by proprietary technology and a strong distribution network through its own channels and third-party retailers.
- Ticker
- Fr. SOON
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 18,580
- Headquarters
- Stäfa, Switzerland
- Website
- www.sonova.com
SOON Metrics
BasicAdvanced
CHF 17B
38.01
CHF 7.22
1.07
CHF 4.70
1.71%
Price and volume
Market cap
CHF 17B
Beta
1.07
52-week high
CHF 278.00
52-week low
CHF 163.00
Average daily volume
121K
Dividend rate
CHF 4.70
Financial strength
Current ratio
1.753
Quick ratio
1.159
Long term debt to equity
0.579
Total debt to equity
0.649
Dividend payout ratio (TTM)
60.92%
Interest coverage (TTM)
24.56%
Profitability
EBITDA (TTM)
841.5
Gross margin (TTM)
73.72%
Net profit margin (TTM)
11.94%
Operating margin (TTM)
19.55%
Effective tax rate (TTM)
14.91%
Revenue per employee (TTM)
CHF 190,000
Management effectiveness
Return on assets (TTM)
7.63%
Return on equity (TTM)
20.52%
Valuation
Price to earnings (TTM)
38.013
Price to revenue (TTM)
4.537
Price to book
6.32
Price to tangible book (TTM)
223.77
Price to free cash flow (TTM)
27.048
Free cash flow yield (TTM)
3.70%
Free cash flow per share (TTM)
10.152
Dividend yield (TTM)
1.71%
Forward dividend yield
1.71%
Growth
Revenue change (TTM)
-0.19%
Earnings per share change (TTM)
-20.10%
3-year revenue growth (CAGR)
-1.20%
10-year revenue growth (CAGR)
5.70%
3-year earnings per share growth (CAGR)
-12.33%
10-year earnings per share growth (CAGR)
3.54%
3-year dividend per share growth (CAGR)
0.72%
10-year dividend per share growth (CAGR)
8.39%
What the Analysts think about SOON
Analyst ratings (Buy, Hold, Sell) for Sonova Holding AG stock.
Analyst projections of the future price of Sonova Holding AG stock.
Bulls say / Bears say
Sonova delivered 5.9% sales growth in local currencies in 2025/26, while its Hearing Instruments business grew 7.5% and normalized EBITA rose 17.3%. Management expects further sales growth of 5–8% and core EBIT growth of 7–10% in 2026/27, suggesting continued market-share gains and operating leverage. (Sonova)
The Phonak EON platform extends Sonova’s real-time AI technology into a smaller and lighter device, with improved speech clarity, lower power use and broader connectivity. Its August launch gives the company a fresh product cycle that could support premium pricing, replacement demand and first-time adoption. (Reuters, Sonova)
Sonova is narrowing its portfolio towards Hearing Instruments and Cochlear Implants while planning to divest Consumer Hearing, and it is targeting CHF 6 billion of revenue by 2030/31. Management sees structural room to grow because hearing-loss adoption remains low, particularly in Asia, and intends to use operational improvements to support expansion. (Sonova)
The Cochlear Implants segment remains a material weakness: 2025/26 sales fell 11.1% in local currencies, with China hit by volume-based procurement and developed markets facing a major competitor’s product launch. Management still expects first-half headwinds in 2026/27, leaving the recovery dependent on a new processor and regulatory approval. (Sonova)
Currency movements are masking operational progress for Swiss-franc investors: 2025/26 reported sales fell 0.2% and reported EBITA fell 5.8%, despite local-currency growth. Sonova expects foreign exchange to cut 2026/27 reported sales growth by 1–2 percentage points and core EBIT growth by 3–4 points. (Sonova)
Competition in hearing aids is intensifying while product-platform cycles are shortening, forcing Sonova to refresh its range more frequently to defend its position. That raises execution risk around the EON launch and could increase research, marketing and pricing pressure if rivals catch up with its AI features. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 28 Sept 2026.
SOON Financial Performance
Revenues and expenses
SOON Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing SOON
AllUSDEURGBP
Fund name | Fund size | Fr. SOON weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced£WHCA | $362M | 0.93% |
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 0.93% |
iShares MSCI Europe Health Care Sector€ESIH | €863M | 0.90% |
iShares MSCI Europe Health Care Sector£ESIH | £741M | 0.90% |
iShares STOXX Europe Mid 200€EXSD | €610M | 0.89% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.